Filing Details

Accession Number:
0001144204-15-071683
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-18 16:03:44
Reporting Period:
2015-12-16
Filing Date:
2015-12-18
Accepted Time:
2015-12-18 16:03:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293310 Kalobios Pharmaceuticals Inc KBIO Pharmaceutical Preparations (2834) 770557236
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1659573 Edward Thomas Fernandez C/O Kalobios Pharmaceuticals, Inc.
442 Littlefield Avenue
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-12-16 6,821 $29.32 6,821 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On December 16, 2015, in connection with a private placement of the Issuer's securities that was announced and priced on December 3, 2015, Thomas Edward Fernandez acquired 6,821 shares of the Issuer's common stock, par value $0.001 per share, at a purchase price of $29.32 per share (which was the announced price for the private placement). The aggregate purchase price paid by Thomas Edward Fernandez in the transaction was $199,991.72.